As suggested by in vitro and in vivo studies, adenoviruses with chimeric Ad5/11 fiber expressing Beclin-1 could be a promising approach in CML therapy (120). Here, BECN1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.